Migraine treatment

Seminars in Neurology

Volumn 17, Issue 4, 1997, Pages 325-332

  Young, William B ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute treatment; Comorbidity; Migraine; Migraine status; Nonpharmacologic treatment; Preventive treatment; Primary headache

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; CHLORPROMAZINE; CORTICOSTEROID; DEXAMETHASONE; DIAZEPAM; DIHYDROERGOTAMINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ERGOTAMINE; FLUNARIZINE; KETOROLAC; MAGNESIUM; METHYLERGOMETRINE; METHYSERGIDE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PHENELZINE; RIBOFLAVIN; RIZATRIPTAN; SEROTONIN ANTAGONIST; SUMATRIPTAN; UNINDEXED DRUG; VALPROATE SEMISODIUM; VERAPAMIL; ZOLMITRIPTAN;

AFFECTIVE NEUROSIS; CARDIOTOXICITY; COMORBIDITY; DROWSINESS; EDEMA; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HALLUCINATION; HEADACHE; HUMAN; HYPERCOAGULABILITY; IMPOTENCE; INHALATIONAL DRUG ADMINISTRATION; INJECTION PAIN; INSOMNIA; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MIGRAINE; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; REBOUND; REVIEW; SEXUAL DYSFUNCTION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; TREMOR; VERTIGO; WEIGHT GAIN;

EID: 0031446495     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040945     Document Type: Article

References (34)

1. Silberstein SD, Saper J. Migraine: diagnosis and treatment. In Dalessio D, Silberstein SD, eds. Wolff's headache and other head pain. 6th ed. New York, NY: Oxford University Press; 1993:96-170
2. Silbersteih SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994;44(supp17):S6-S16
3. Andreychuk T, Skriver C. Hypnosis and biofeedback in the treatment of migraine headache. Int J Clin Exp Hypn 1975;23(3): 172-83.
4. Budzynski TH, Stoyva JM, Adler CS. Feedback-induced muscle relaxation: application to tension headache. J Behav Ther Exp Psychiatr 1970;1:205-11
5. Sargent JP, Green EE, Walters ED. Preliminary report on the use of autogenic feedback training in the treatment of migraine and tension headaches. Psychosom Med 1973;35:129
6. McCrory DC, Penzien DB, Rains JC, Hasselblad V. Efficacy of behavioral treatments for migraine and tension-type headache: meta-analysis of controlled trials. Headache 1996;36(4):272. Abstract.
7. Anthony M. Arrest of attacks of cluster headache by local steroid injection of the occipital nerve. In Rose FC, ed. Migraine -Clinical and Research Aspects. Basel: Karger; 1985:169
8. Silberstein SD, Lipton RB, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia 1995;15:358-69
9. Dalessio DJ, ed. Wolff's Headache and Other Head Pain. 4th ed. New York, NY: Oxford University Press, 1980
10. Lauritzen M. Spreading cortical depression as a mechanism of the aura in classic migraine. In Amery WK, Wauquier A, eds. The Prelude to the Migraine Attack. London: Bailliere Tindall; 1986:134-41
11. Goldner JA, Levitt LP. Treatment of complicated migraine with sublingual nifedipine. Headache 1987;27:484-6
12. Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997:48:261-2
13. Tfelt-Hansen P, Lipton RB. Prioritizing treatment. In Diesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York, NY: Raven Press; 1993:359-62
14. Chabriat H, Joire JE, Danchot J, Grippon P, Bousser MG. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study. Cephalalgia 1994;14:297-300
15. Sawynok J, Yaksh TL. Caffeine as analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 1993; 45:43-85
16. Friedman AP, Boyles WF, Elkind AH, Fillingim J, et al. Fiorinal with codeine in the treatment of tension headache-the contribution of components to the combination drug. Clinic Therap 1988;10(3):303-15
17. Ryan RE. A study of Midrin in the symptomatic relief of migraine headache. Headache 1974;14:33-42
18. Yuill GM, Swinburn WR, Liversedge LA. A double-blind cross-over trial of Isometheptene mucate compound and ergotamine in migraine. Brit J Clin Prac 1972;26:76-9
19. Tfelt-Hansen P, Lipton RB. Miscellaneous drugs. In Diesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York, NY: Raven Press; 1993:353-8
20. Bowdle TA, Galer BS. Agonist-antagonist and partial agonist opioids: pharmacologie mechanisms and clinical application in the treatment of headache. Headache Quarterly 1993;4:322-36
21. Lipton RB, Tfelt-Hansen P. Neuroleptics. In Diesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York, NY: Raven Press; 1993:349-52
22. Wang S-J, Silberstein SD, Young WB. Droperidol treatment of acute refractory migraine and status migrainosus. Headache. In press.
23. Silberstein SD, Young WB. Safety and efficacy of ergotamine tartrate and DHE in the treatment of migraine and status migrainosus. Neurology 1995;45:577-84
24. Celentano DD, Stewart WF, Lipton RB, et al. Medication use and disability among migraineurs: a national probability sample. Headache 1992;32:223-8
25. Silberstein SD, Lipton RL. Migraine epidemiology. Neurol Clin 1996;14:421-34
26. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996;36(3): 154-60. Abstract.
27. Wilson CB, Rose JP. Repetitive intravenous chlorpromazine, an alternative to repetitive DHE protocol. Headache 1996;36(4): 281. Abstract.
28. Silberstein SD. Migraine and pregnancy. Neurol Clin 1997; 15:209-31
29. Tfelt-Hansen P, Welch KMA. Prioritizing prophylactic treatment. In Diesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York, NY: Raven Press; 1993:403-4
30. Silberstein SD. Divalproex sodium in headache-literature review and clinical guidelines. Headache 1996;36(9):547-55
31. Tfelt-Hansen P, Shanks RG. Beta-adrenoceptor blocking drugs. In Diesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York, NY: Raven Press; 1993:363-72
32. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization, and cost. Cephalalgia 1997. In press.
33. Ophoff RA, Van Eijk R, Sandkuijl LA, et al. Genetic heterogeneity of familial hemiplegie migraine. Genomics 1994;22:21-6
34. Sôrensen PS, Hansen K, Diesen J. A placebo-controlled, double-